AFLD 2016 FFHMFAC vs Respondent M12

21 Jan 2016

On 12 June 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) decided to impose a 4 month period of ineligibility on the Athlete after he tested positive for the prohibited substance Oxilofrine (Methylsynephrine).

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete filed a statement in his defence.

The Athlete admitted the violation, denied the intentional use of the substance and explained that the source was a supplement he had used. He acknowledged that he acted negligently as he had not checked this supplement before using.

The AFLD determines that:

  • The Athlete had committed an anti-doping rule violation;
  • He failed to check the ingredients on the label of this supplement;
  • He did not mention the supplement on the Doping Control Form;
  • He established how the substance had entered his system;
  • He acted with siginificant fault or negligece.

Therefore the AFLD decides on 21 January 2016 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 June 2015.

AFLD 2016 FFA vs Respondent M11

21 Jan 2016

In February 2015 the Athlete tested positive for the prohibited substances Prednisolone and Prednisone. Thereupon the French Athletics Federation (FFA) failed to render timely a decision and the case was referred to French Anti-Doping Agency (AFLD). Following notification the Athlete filed a statement in his defence.

The Athlete acknowledged that at the material time he daily had used Prednisolone as treatment for his diagnosed condition. He mentioned this medication on the Doping Control Form and produced a medical certificate of his physician in Kenya.

The AFLD determines that:

  • The Athlete had committed an anti-doping rule violation;
  • The violation was not intentional;
  • He failed to produce a prescription, nor documents regarding his diagnosed condition;
  • He mentioned his medication on the Doping Control Form;
  • He acted with No Significant Fault or Negligence.

Therefore the AFLD decides on 21 January 2016 to impose a 6 month period of ineligibility on the Athlete.

AFLD 2016 FFPJP vs Respondent M10

21 Jan 2016

On 19 June 2015 the French Pétanque Bowls Federation (FFPJP) Disciplinary Panel decided to impose a 1 year period of ineligibility on the Athlete after he tested positive for the prohibited substances Methyltestosterone and Stanozolol.

Hereafter the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete admitted the violation and denied the intentional use of the substances. He explained without corroborating evidence that in the three week before the Doping Control he had used pills, provided by a friend, to improve his libido, .

The AFLD determines that:

  • The presence of prohibited substances has been established in his sample and accordingly he committed an anti-doping rule violation; and
  • The violations was not intentional although he acted negligently.

Therefore the AFLD decides on 21 January 2016 to impose a 2 year period of ineligibility on the Athlete.

AFLD 2016 FFSQ vs Respondent M09

21 Jan 2016

On 3 October 2015 the French Squash Federation (FFSQ) Appeal Panel decided to impose a 1 month period of ineligibility on the Athlete after she tested positive for the prohibited substances Prednisolone and Prednisone.

Hereafter the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in her defence and she was heard.

The Athlete admitted the violation, denied the intentional use and acknowledged that she acted negligently. She explained with medical evidence that she had used the medication Solupred for her neck pain she suffered since 2014.

The AFLD determines that:

  • The presence of a prohibited substance has been established in her sample and accordingly she committed an anti-doping rule violation;
  • She acted negligently and failed to demonstrate that the violation was not intentional;
  • She self-medicated and used the medication prescribed for her daughter;
  • She failed to check this medication, nor mention this on the Doping Control Form;
  • She already had received Codeine tablets from her doctor as painkillers.

Therefore the AFLD decides on 21 January 2016 to impose a 2 year period of ineligibility on the Athlete.

AFLD 2016 FFKMDA vs Respondent M08

21 Jan 2016

On 26 June 2015 the French Federation for Kick Boxing, Muay Thai and Associated Disciplines (FFKMDA) decided to impose a 1 year period of ineligibility on the Athlete after he tested positive for the prohibited substance Oxilofrine (Methylsynephrine).

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete admitted the violation and denied the intentional use of the substance. He explained that he had used a supplement Lipo-6 Black, recommended by a person he knew, in order to to lose weight.

The AFLD determines that:

  • The Athlete had committed an anti-doping rule violation;
  • He had used the prohibited substance without a medical justification;
  • He failed to check the ingredients on the label of this supplement;
  • He did not mention the supplement on the Doping Control Form;
  • He established how the substance had entered his system;
  • He acted negligently and failed to demonstrate that the violation was not intentional.

Therefore the AFLD decides on 21 January 2016 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 11 June 2015.

AFLD 2016 FFHB vs Respondent M07

21 Jan 2016

On 3 August 2015 the French Handball Federation (FFHB) decided to impose a warning on the handball player after she tested positive for the prohibited substances Prednisolone and Prednisone.

Hereafter the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in her defence.

The Athlete admitted the violation and denied the intentional use of the substances.  She explained with evidence that she had used the prescribed medication Solupred for the allergic reaction she suffered in May 2015 due to an insect sting.

The Athlete asserted that she had mentioned her medication on the Doping Control Form. With her doctor she also made a TUE application in July 2015 for this medication.

The AFLD determines that:

  • The Athlete had received a prescription for Solupres 3 months before;
  • She self-medicated and did not follow the instructions of the prescription;
  • She failed to demonstrate with evidence that she suffered from an allergic reaction in May 2015;
  • The retrospective TUE application from July 2015 was invalid;
  • The Athlete acted with a degree of negligence.

Therefore the AFLD decides on 21 January 2016 to impose a 6 month period of ineligibility on the Athlete.

AFLD 2016 FFHMFAC vs Respondent M06

7 Jan 2016

On 30 June 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) decided to impose a 2 year period of ineligibility on the powerlifter after he tested positive for the prohibited substance Stanozolol.

Hereafter the French Anti-Doping Agency (AFLD) reopened the case. Following notification the Athlete filed a statement in his defence and he did not attend the hearing.

The Athlete denied the intentional use of the substance and acknowledged that he had acted negligently. He explained that he had used recommended supplements provided by a person he knew in order to recover from an injury.

The AFLD finds that the Athlete had committed an anti-doping rule violation and that he has not established that the violation was not intentional. Not only had the Athlete acted negligently and also he failed to demonstrate with evidence that there was a medical justification for the use of the prohibited substance.

Therefore the AFLD decides on 7 January 2016 to extend the sanction imposed on the Athlete.

AFLD 2016 FFC vs Respondent M05

7 Jan 2016

On 21 July 2015 the French Cycling Federation (FCC) Appeal Panel decided to  impose a reduced 3 month period of ineligibility on the cyclist for his evasion, refusal or failure to submit to sample collection. 

The Doping Control Officers reported that the selected Athlete failed to appear for sample collection at a competition in April 2015.

Hereafter the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete admitted the violation, denied that he acted intentionally and requested for a reduced sanction. He asserted that he was unaware that he had been selected for sample collection, nor was he notified.

The Athlete argued that he was present at the finish line and that he also had not received a telephone call. The next day he provided a sample which tested negative for banned substances.

The AFLD deems that the Athlete's violation was not intentional. Further the AFLD considers that he acted with a degree of  fault and negligence and that he was tested the next day. Moreover the AFLD establishes that at the competition no chapperonnes were available, neither the telephone number to contact the Athlete.

Therefore the AFLD decides on 7 January 2016 to impose a 1 year period of ineligibility on the Athlete.

AFLD 2016 FFC vs Respondent M04

7 Jan 2016

On 24 June 2015 the French Cycling Federation (FCC) Appeal Panel decided to impose a 1 year period of ineligibility on the cyclist after his sample tested positive for the prohibited substance Triamcinolone acetonide.

Hereafter the case was reopened by the French Anti-Doping Agency (AFLD). Following notification the Athlete filed a statement in his defence and failed to attend the hearing.

The AFLD finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. 

The AFLD determines that the Athlete had mentioned his medication on th Doping Control Form and that his application for a TUE was denied in March 2015. The AFLD deems that the Athlete failed to explain how he obtained this medication, nor did he provide a medical justification for the use of this medication.

Therefore the AFLD decides on 7 January 2016 to impose a 2 year period of ineligiblity on the Athlete.

AFLD 2016 FFKMDA vs Respondent M03

7 Jan 2016

On 26 June 2015 the French Federation for Kick Boxing, Muay Thai and Associated Disciplines (FFKMDA) decided to impose a 2 year period of ineligibility on the muay thai Athlete after he tested positive for the prohibited substances Methylenedioxymethamphetamine (MDMA) and Methylenedioxyamphetamine (MDA).

Hereafter the case was reopened by the AFLD. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete admitted the violation, denied the intentional use and requested for a reduced sanction. He explained that he had used tablets recreationally 2 weeks before the sample collection.

The AFLD considers that the Athlete had used prohibited and illegal substances without a medical justification. Further the AFLD deems that the concentration found in his sample was not consistent with his alleged use 2 weeks before the Doping Control.

Therefore the AFLD decides on 7 January 2016 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 13 March 2015.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin